Search results
Results from the WOW.Com Content Network
The authors also found a substantial link between baseline BCS and depression risk among those younger than 50 — which they considered surprising since they expected only older adults may have ...
A history of two or more prior head injuries was associated with over two times increased risk of dementia. Be physically active Studies show that being physically active can help lower your risk ...
[7] [10] [83] Mirtazapine and SSRIs can be used to treat depression, depending on how well they are tolerated, and guided by general advice for the use of antidepressants in dementia. [65] Antidepressants with anticholinergic properties may worsen hallucinations and delusions. [86] People with Capgras syndrome may not tolerate AChEIs. [64]
In people with a greater baseline score (>30 on HAMD17 scale), the agomelatine-placebo difference was of 4.53 points. [15] Controlled studies in humans have shown that agomelatine is at least as effective as the SSRI antidepressants paroxetine , sertraline , escitalopram , and fluoxetine in the treatment of major depression . [ 16 ]
Typically, dementia is associated with classic symptoms like confusion and memory loss. But new research finds that there could be a less obvious risk factor out there: your cholesterol levels ...
Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of psychiatric drugs used primarily as antidepressants. [1] They act by antagonizing the α 2 -adrenergic receptor and certain serotonin receptors such as 5-HT 2A and 5-HT 2C , [ 1 ] but also 5-HT 3 , [ 1 ] 5-HT 6 , and/or 5-HT 7 in some cases.
Dementia. A recent study carried out by experts from the University of Nottingham and funded by the National Institute for Health Research (NIHR) has shown there to be an increased risk of up to 50% of patients developing Dementia due to some of these medications and cautions have been advised with their use.
Not only that, they had a 52 percent lower risk of vascular dementia, and a 39 percent lower risk of Alzheimer’s dementia. People who took SGLT-2 inhibitors for longer periods of time seemed to ...